HeartSciences (HSCS) EBT Growth (1y) (2022 - 2026)
HeartSciences (HSCS) EBT Growth (1y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | -29.12% |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 53.94% |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 45.44% |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 12.65% |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 29.89% |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 31.69% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 13.05% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 71.38% |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 17.94% |
| 10 | HeartSciences | 6.45 Mn | 4.75 Mn | - | -31.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -31.57% |
| Oct 31, 2025 | 85.34% |
| Jul 31, 2025 | -10.53% |
| Apr 30, 2025 | -10.55% |
| Jan 31, 2025 | -18.61% |
| Oct 31, 2024 | -15.02% |
| Jul 31, 2024 | -17.51% |
| Apr 30, 2024 | -16.42% |
| Jan 31, 2024 | -15.03% |
| Oct 31, 2023 | -11.23% |
| Jul 31, 2023 | -12.61% |
| Apr 30, 2023 | 20.55% |
| Jan 31, 2023 | -903.18% |
| Oct 31, 2022 | -1,112.15% |
| Jul 31, 2022 | -1,476.03% |